Evidence map›Paper›PMID 32606666›Full record

ArticleInternational journal of nanomedicine2020

Size-Dependent Interactions of Lipid-Coated Gold Nanoparticles: Developing a Better Mechanistic Understanding Through Model Cell Membranes and in vivo Toxicity.

Arek M Engstrom, Ryan A Faase, Grant W Marquart, Joe E Baio, Marilyn R Mackiewicz, Stacey L Harper

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Translocation of TiRSC advances · 2024
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Arek M EngstromDepartment of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, United States.ORCID 0000-0002-0988-6309
Ryan A FaaseSchool of Chemical, Biological, and Environmental Engineering, Oregon State University, Corvallis, OR, United States.ORCID 0000-0001-9825-4903
Grant W MarquartDepartment of Chemistry, Portland State University, Portland, OR, United States.ORCID 0000-0002-4554-2431
Joe E BaioSchool of Chemical, Biological, and Environmental Engineering, Oregon State University, Corvallis, OR, United States.
Marilyn R MackiewiczDepartment of Chemistry, Portland State University, Portland, OR, United States.ORCID 0000-0002-5669-8714
Stacey L HarperDepartment of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, United States.ORCID 0000-0001-7043-7097

Funding

Microfluidic Photoreactor for Treatment of HyperbilirubinemiaR21HD096301 · NICHD · OREGON STATE UNIVERSITY · PI BAIO, JOE E, HIGGINS, ADAM Z · 2018 to 2019
$372k
NICHD NIH HHS R21 HD096301
6 · The paper itself

Abstract

introductionHumans are intentionally exposed to gold nanoparticles (AuNPs) where they are used in variety of biomedical applications as imaging and drug delivery agents as well as diagnostic and therapeutic agents currently in clinic and in a variety of upcoming clinical trials. Consequently, it is critical that we gain a better understanding of how physiochemical properties such as size, shape, and surface chemistry drive cellular uptake and AuNP toxicity in vivo. Understanding and being able to manipulate these physiochemical properties will allow for the production of safer and more efficacious use of AuNPs in biomedical applications. METHODS AND MATERIALS: Here, AuNPs of three sizes, 5 nm, 10 nm, and 20 nm, were coated with a lipid bilayer composed of sodium oleate, hydrogenated phosphatidylcholine, and hexanethiol. To understand how the physical features of AuNPs influence uptake through cellular membranes, sum frequency generation (SFG) was utilized to assess the interactions of the AuNPs with a biomimetic lipid monolayer composed of a deuterated phospholipid 1.2-dipalmitoyl-d62-sn-glycero-3-phosphocholine (dDPPC). RESULTS AND DISCUSSION: SFG measurements showed that 5 nm and 10 nm AuNPs are able to phase into the lipid monolayer with very little energetic cost, whereas, the 20 nm AuNPs warped the membrane conforming it to the curvature of hybrid lipid-coated AuNPs. Toxicity of the AuNPs were assessed in vivo to determine how AuNP curvature and uptake influence cell health. In contrast, in vivo toxicity tested in embryonic zebrafish showed rapid toxicity of the 5 nm AuNPs, with significant 24 hpf mortality occurring at concentrations ≥20 mg/L, whereas the 10 nm and 20 nm AuNPs showed no significant mortality throughout the five-day experiment.

conclusionBy combining information from membrane models using SFG spectroscopy with in vivo toxicity studies, a better mechanistic understanding of how nanoparticles (NPs) interact with membranes is developed to understand how the physiochemical features of AuNPs drive nanoparticle-membrane interactions, cellular uptake, and toxicity.

Indexed as

Membranes, ArtificialParticle SizeToxicity TestsAnimalsCell MembraneEmbryo, NonmammalianGoldHumansLipidsMetal NanoparticlesSpectrophotometry, UltravioletSpectrum AnalysisZebrafishGoldLipidsMembranes, Artificialgold nanoparticlehybrid lipid-coated nanoparticlenanoparticle–biological interactionssize-dependent interactiontoxicityvibrational spectroscopyzebrafish

Identifiers

PMID32606666
PMCPMC7295544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.